Valuation: genOway

Market Cap 2.03Cr 2.28Cr 1.88Cr 1.71Cr 3.21Cr 215.75Cr 3.26Cr 23Cr 8.86Cr 112.76Cr 8.54Cr 8.36Cr 360.47Cr P/E 2024 *
-
P/E 2025 -
Enterprise Value 2.7Cr 3.03Cr 2.5Cr 2.27Cr 4.27Cr 287.2Cr 4.34Cr 30Cr 12Cr 150.11Cr 11Cr 11Cr 479.85Cr EV / Sales 2024
1.36x
EV / Sales 2025 1.22x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day+0.91%
1 week-0.89%
Current month-5.13%
1 month-10.48%
3 months-10.48%
6 months-11.20%
Current year-18.08%
1 week 2.09
Extreme 2.09
2.26
1 month 2.01
Extreme 2.01
2.5
Current year 2.01
Extreme 2.01
2.79
1 year 2.01
Extreme 2.01
2.88
3 years 2.01
Extreme 2.01
4.91
5 years 2.01
Extreme 2.01
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 01/03/1999
Director of Finance/CFO - 01/10/2015
Director TitleAgeSince
Director/Board Member - 01/03/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
20/01/22 Buy

Chief Executive Officer

12,500 0.1376%
17/11/21 Sell

Chief Executive Officer

5,000 0.0553%
13/11/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%-0.89%-19.86%-44.36% 2.28Cr
+1.52%-7.19%+51.66%+69.99% 6.58TCr
-0.54%+6.83%+10.77%+79.30% 5.19TCr
+1.53%+3.15%+1.53%+63.51% 5.12TCr
-0.38%+1.40%+29.98%+42.37% 4.38TCr
+0.30%+5.64%+16.99%+133.30% 4.21TCr
+2.35%-6.08%+236.69%+528.10% 3.9TCr
+2.16%+9.87%+18.92%+59.70% 3.4TCr
+4.15%-1.95%+39.74%+9.00% 2.52TCr
+0.55%+2.21%+21.34%+28.00% 2.28TCr
Average +1.28%+0.15%+40.78%+96.89% 3.76TCr
Weighted average by Cap. +1.16%+0.20%+46.40%+114.28%

Financials

2024 2025
Net sales 2.58Cr 2.9Cr 2.39Cr 2.18Cr 4.08Cr 274.86Cr 4.15Cr 29Cr 11Cr 143.66Cr 11Cr 11Cr 459.24Cr 2.6Cr 2.92Cr 2.41Cr 2.19Cr 4.11Cr 276.86Cr 4.18Cr 29Cr 11Cr 144.7Cr 11Cr 11Cr 462.57Cr
Net income 18.31L 20.54L 16.96L 15.42L 28.93L 19Cr 29.41L 2.03Cr 79.99L 10Cr 77.06L 75.44L 33Cr 9L 10.41L 9L 8L 14.66L 9.87Cr 14.9L 1.03Cr 40.53L 5.16Cr 39.05L 38.23L 16Cr
Net Debt 6L 7L 6L 5L 10L 6.63Cr 10.01L 69.22L 27.22L 3.46Cr 26.22L 25.67L 11Cr 67.18L 75.37L 62.23L 56.58L 1.06Cr 71Cr 1.08Cr 7.46Cr 2.94Cr 37Cr 2.83Cr 2.77Cr 119.39Cr
Projected Income Statement - Annual - genOway
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
163
Date Price Change Volume
20/26/20 €2.220 +0.91% 50
19/26/19 €2.200 +2.33% 10,994
16/26/16 €2.150 -0.92% 681
15/26/15 €2.170 -3.13% 5,985
14/26/14 €2.240 0.00% 763
  1. Stock Market
  2. Stocks
  3. ALGEN Stock